Literature DB >> 16912209

Sequence variants in cell cycle control pathway, X-ray exposure, and lung cancer risk: a multicenter case-control study in Central Europe.

Rayjean J Hung1, Paolo Boffetta, Federico Canzian, Norman Moullan, Neonila Szeszenia-Dabrowska, David Zaridze, Jolanta Lissowska, Peter Rudnai, Eleonora Fabianova, Dana Mates, Lenka Foretova, Vladimir Janout, Vladimir Bencko, Amelie Chabrier, Stefano Landi, Federica Gemignani, Janet Hall, Paul Brennan.   

Abstract

Exposure to ionizing radiation (IR) results in various types of DNA damage and is a suspected cause of lung cancer. An essential cellular machinery against DNA damage is cell cycle control, which is regulated by several genes, including TP53, CCND1, and CDKN2A. Therefore, we hypothesized that the genetic variants in these three genes influence the predisposition of lung cancer (i.e., CCND1 G870A, CDKN2A Ala(148)Thr, TP53 Arg(72)Pro, and 16-bp repeat in intron 3) and that the effect of X-ray on lung cancer risk can be modified by the presence of these genetic variations. The study was conducted in 15 centers in 6 countries of Central Europe between 1998 and 2002. A total of 2,238 cases and 2,289 controls were recruited and provided DNA samples. Cases with positive family history were analyzed separately. The joint effect of X-ray and previous risk genotypes was assessed, and modification by sequence variants on X-ray dose-response relationship with lung cancer risk was evaluated. We found an overall effect of TP53 intron 3 16-bp repeats [odds ratio (OR), 1.99; 95% confidence interval (95% CI), 1.27-3.13], which was stronger among cases with family history of lung cancer (OR, 2.98; 95% CI, 1.29-6.87). In addition, our results suggested an interaction that was greater than multiplicativity between TP53 intron 3 16-bp repeats and multiple X-ray exposures (interaction OR, 5.69; 95% CI, 1.33-24.3). We did not observe a main effect of CCND1 G870A polymorphism; however, the dose-response relationship between lung cancer risk and X-ray exposures was modified by CCND1 genotype with no risk from X-ray exposures among subjects who carried G/G genotype, intermediate risk [trend OR for X-ray, 1.16; 95% CI, 1.05-1.27) among subjects with G/A genotype, and highest risk [trend OR for X-ray, 1.29; 95% CI, 1.12-1.49) among subjects with A/A genotype. Sequence variants in cell cycle control pathway may increase the risk of lung cancer and modify the risk conferred by multiple X-ray exposures. However, a definite conclusion can only be drawn on replication by different studies among individuals who are highly exposed to IR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912209     DOI: 10.1158/0008-5472.CAN-05-3099

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Xiang-Hua Ye; Zhi-Bin Bu; Jie Feng; Ling Peng; Xin-Biao Liao; Xin-Li Zhu; Xiao-Li Sun; Hao-Gang Yu; Dan-Fang Yan; Sen-Xiang Yan
Journal:  Mol Biol Rep       Date:  2013-11-23       Impact factor: 2.316

2.  International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.

Authors:  Therese Truong; Wiebke Sauter; James D McKay; H Dean Hosgood; Carla Gallagher; Christopher I Amos; Margaret Spitz; Joshua Muscat; Philip Lazarus; Thomas Illig; H Erich Wichmann; Heike Bickeböller; Angela Risch; Hendrik Dienemann; Zuo-Feng Zhang; Behnaz Pezeshki Naeim; Ping Yang; Shanbeh Zienolddiny; Aage Haugen; Loïc Le Marchand; Yun-Chul Hong; Jin Hee Kim; Eric J Duell; Angeline S Andrew; Chikako Kiyohara; Hongbing Shen; Keitaro Matsuo; Takeshi Suzuki; Adeline Seow; Daniel P K Ng; Qing Lan; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Vali Constantinescu; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Neil E Caporaso; Demetrius Albanes; Michael Thun; Maria Teresa Landi; Joanna Trubicka; Marcin Lener; Jan Lubinski; Ying Wang; Amélie Chabrier; Paolo Boffetta; Paul Brennan; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2010-01-27       Impact factor: 4.944

3.  CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.

Authors:  Yu-Zhong Duan; Liang Zhang; Chang-Chih Liu; Bo Zhu; Wen-Lei Zhuo; Zheng-Tang Chen
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

Review 4.  The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.

Authors:  Qian Qiao; Weiguo Hu
Journal:  Lung       Date:  2013-04-18       Impact factor: 2.584

5.  Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.

Authors:  Jianming Liu; Qiande Liao; Yangde Zhang; Shenghua Sun; Caigao Zhong; Xinmin Liu
Journal:  Tumour Biol       Date:  2012-04-24

6.  The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.

Authors:  Changxi Zhou; Huaijie An; Mingdong Hu; Qinghui Liu; Peiliang Geng; Jiancheng Xu; Baojun Sun; Changting Liu
Journal:  Tumour Biol       Date:  2013-07-20

7.  Combination of genetic variants in cyclin D1 and retinoblastoma genes predict clinical outcome in oral cancer patients.

Authors:  Abitha Murali; Bipin T Varghese; R Rejnish Kumar; S Kannan
Journal:  Tumour Biol       Date:  2015-10-12

8.  Hypermethylation of the 5' CpG island of the p14ARF flanking exon 1β in human colorectal cancer displaying a restricted pattern of p53 overexpression concomitant with increased MDM2 expression.

Authors:  Christine Nyiraneza; Christine Sempoux; Roger Detry; Alex Kartheuser; Karin Dahan
Journal:  Clin Epigenetics       Date:  2012-06-15       Impact factor: 6.551

9.  International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways.

Authors:  Rayjean J Hung; David C Christiani; Angela Risch; Odilia Popanda; Aage Haugen; Shan Zienolddiny; Simone Benhamou; Christine Bouchardy; Qing Lan; Margaret R Spitz; H-Erich Wichmann; Loic LeMarchand; Paolo Vineis; Giuseppe Matullo; Chikako Kiyohara; Zuo-Feng Zhang; Benhnaz Pezeshki; Curtis Harris; Leah Mechanic; Adeline Seow; Daniel P K Ng; Neonila Szeszenia-Dabrowska; David Zaridze; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Lenka Foretova; Vladimir Janout; Vladimir Bencko; Neil Caporaso; Chu Chen; Eric J Duell; Gary Goodman; John K Field; Richard S Houlston; Yun-Chul Hong; Maria Teresa Landi; Philip Lazarus; Joshua Muscat; John McLaughlin; Ann G Schwartz; Hongbing Shen; Isabelle Stucker; Kazuo Tajima; Keitaro Matsuo; Michael Thun; Ping Yang; John Wiencke; Angeline S Andrew; Stephanie Monnier; Paolo Boffetta; Paul Brennan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

10.  Genetic association between cyclin D1 polymorphism and breast cancer susceptibility.

Authors:  XiaoRui Li; XiaoQing Huo; WeiWei Li; QingHui Yang; Ying Wang; XiaoChun Kang
Journal:  Tumour Biol       Date:  2014-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.